Top

International Urogynecology Journal

Published in:

01-08-2020 | Obesity | Original Article

Obesity and its long-term impact on sacrocolpopexy key outcomes (OBELISK)

Authors: Martin Smazinka, Vladimir Kalis, Martin Havir, Linda Havelkova, Khaled M. Ismail, Zdenek Rusavy

Published in: International Urogynecology Journal | Issue 8/2020

Abstract

Introduction and hypothesis

Sacrocolpopexy is the preferred contemporary approach to managing significant apical pelvic organ prolapse. Obesity is an established risk factor for several surgical procedures and can have a negative impact on outcomes. Our goal was to evaluate the impact of BMI on the safety and efficacy of laparoscopic sacrocolpopexy in women with pelvic organ prolapse.

Methods

A single-center retrospective observational study of women undergoing laparoscopic sacrocolpopexy between January 1, 2015, and December 31, 2017.

Results

We found 299 procedures: 82 (27.4%), 147 (49.2%) and 70 (23.4%) in women with BMI <25 (normal weight), BMI ≥ 25 – < 30 (overweight) and BMI ≥ 30 (obese), respectively. Perioperative and early postoperative complications were generally low and not statistically significantly different between the groups. At 12 months postoperatively, 81 (98.8%), 136 (92.5%) and 62 (88.6%) normal-weight, overweight and obese women attended their follow-up, respectively. All obese women attending the follow-up scored an overall Patient Global Impression of Improvement (PGI-I) of ≤ 3. The Pelvic Floor Distress Inventory (PFDI) scores showed a significant improvement in all domains and were similar between the study groups. In total, there was one (0.4%) anatomical apical compartment failure, three (1.1%) anterior compartment failures and two (0.7%) posterior compartment failures with no significant differences between the groups. Similarly, there were no differences in functional outcomes or mesh position as assessed by ultrasound.

Conclusions

There were no differences in surgical, short- and long-term outcomes of laparoscopic sacrocolpopexy for pelvic organ prolapse in obese compared with non-obese women.

Available only for authorised users

Engin A. (2017) The definition and prevalence of obesity and metabolic syndrome. In: Engin A., Engin A. (eds) Obesity and lipotoxicity. Adv Exp Med Biol, vol 960. Springer, Cham

Vidra N, Bijlsma MJ, Trias-Llimós S, Janssen F. Past trends in obesity-attributable mortality in eight European countries: an application of age–period–cohort analysis. Int J Public Health. 2018. https://doi.org/10.1007/s00038-018-1126-2.

Bradley CS, Kenton KS, Richter HE, et al. Obesity and outcomes after sacrocolpopexy. Am J Obstet Gynecol. 2008;199:690.e1–8. https://doi.org/10.1016/j.ajog.2008.07.030.CrossRef

Halder GE, Salemi JL, Hart S, Mikhail E. Association between obesity and perioperative morbidity in open versus laparoscopic sacrocolpopexy. Female Pelvic Med Reconstr Surg. 2017;23:146–50. https://doi.org/10.1097/SPV.0000000000000382.CrossRefPubMed

Haylen BT, Maher CF, Barber MD, et al. Erratum to: an International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic organ prolapse (POP). Int Urogynecol J. 2016;27:655–84. https://doi.org/10.1007/s00192-016-3003-y.CrossRefPubMed

Weber AM, Abrams P, Brubaker L, et al. The standardization of terminology for researchers in female pelvic floor disorders. Int Urogynecol J Pelvic Floor Dysfunct. 2001;12:178–86. https://doi.org/10.1007/PL00004033.CrossRefPubMedPubMedCentral

Barber MD, Maher C. Epidemiology and outcome assessment of pelvic organ prolapse. Int Urogynecol J. 2013;24:1783–90. https://doi.org/10.1007/s00192-013-2169-9.CrossRefPubMed

Augusto KL, Bezerra LRPS, Murad-Regadas SM, et al. Defecatory dysfunction and fecal incontinence in women with or without posterior vaginal wall prolapse as measured by pelvic organ prolapse quantification (POP-Q). Eur J Obstet Gynecol Reprod Biol. 2017;214:50–5. https://doi.org/10.1016/j.ejogrb.2017.04.039.CrossRefPubMed

Giri A, Hartmann KE, Hellwege JN, et al. Obesity and pelvic organ prolapse: a systematic review and meta-analysis of observational studies. Am J Obstet Gynecol. 2017;217:11–26.e3. https://doi.org/10.1016/j.ajog.2017.01.039.CrossRefPubMed

10.

Dieter AA, Edenfield AL, Weidner AC, Siddiqui NY. How does site of pelvic organ prolapse repair affect overactive bladder symptoms? Female Pelvic Med Reconstr Surg. 2014;20:203–7. https://doi.org/10.1097/SPV.0000000000000087.CrossRefPubMed

11.

Lowenstein L, Gamble T, Deniseiko Sanses TV, et al. Sexual function is related to body image perception in women with pelvic organ prolapse. J Sex Med. 2009;6:2286–91. https://doi.org/10.1111/j.1743-6109.2009.01329.x.CrossRefPubMed

12.

Espuña-Pons M, Fillol M, Pascual MA, et al. Pelvic floor symptoms and severity of pelvic organ prolapse in women seeking care for pelvic floor problems. Eur J Obstet Gynecol Reprod Biol. 2014;177:141–5. https://doi.org/10.1016/j.ejogrb.2014.03.050.CrossRefPubMed

13.

Bilgic D, Gokyildiz S, Kizilkaya Beji N, et al. Quality of life and sexual functıon in obese women with pelvic floor dysfunction. Women Health. 2019;59:101–13. https://doi.org/10.1080/03630242.2018.1492497.CrossRefPubMed

14.

Whitcomb EL, Lukacz ES, Lawrence JM, et al. Prevalence and degree of bother from pelvic floor disorders in obese women. Int Urogynecol J. 2009;20:289–94. https://doi.org/10.1007/s00192-008-0765-x.CrossRef

15.

Maher C, Feiner B, Baessler K, Schmid C. Surgical management of pelvic organ prolapse in women. In: Maher C, editor. Cochrane database of systematic reviews. Chichester: Wiley; 2013.

16.

Barber MD, Maher C. Apical prolapse. Int Urogynecol J. 2013;24:1815–33. https://doi.org/10.1007/s00192-013-2172-1.CrossRefPubMed

17.

Costantini E, Brubaker L, Cervigni M, et al. Sacrocolpopexy for pelvic organ prolapse: evidence-based review and recommendations. Eur J Obstet Gynecol Reprod Biol. 2016;205:60–5. https://doi.org/10.1016/j.ejogrb.2016.07.503.CrossRefPubMed

18.

De Gouveia De Sa M, Claydon LS, Whitlow B, Dolcet Artahona MA. Laparoscopic versus open sacrocolpopexy for treatment of prolapse of the apical segment of the vagina: a systematic review and meta-analysis. Int Urogynecol J. 2016;27:3–17. https://doi.org/10.1007/s00192-015-2765-y.CrossRefPubMed

19.

Barber MD, Kuchibhatla MN, Pieper CF, Bump RC. Psychometric evaluation of 2 comprehensive condition-specific quality of life instruments for women with pelvic floor disorders. Am J Obstet Gynecol. 2001;185:1388–95. https://doi.org/10.1067/mob.2001.118659.CrossRefPubMed

20.

Srikrishna S, Robinson D, Cardozo L. Validation of the patient global impression of improvement (PGI-I) for urogenital prolapse. Int Urogynecol J. 2010;21:523–8. https://doi.org/10.1007/s00192-009-1069-5.CrossRefPubMed

21.

Haylen BT, Freeman RM, Swift SE, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint terminology and classification of the complications related directly to the insertion of prostheses (meshes, implants, tapes) and grafts in female pelvic floor surgery. Int Urogynecol J. 2011;22:3–15. https://doi.org/10.1007/s00192-010-1324-9.CrossRefPubMed

22.

Gutman RE, Rardin CR, Sokol ER, et al. Vaginal and laparoscopic mesh hysteropexy for uterovaginal prolapse: a parallel cohort study. Am J Obstet Gynecol 2017;216:38.e1–11.

23.

Dietz HP, Haylen BT, Broome J. Ultrasound in the quantification of female pelvic organ prolapse. Ultrasound Obstet Gynecol. 2001;18:511–4. https://doi.org/10.1046/j.0960-7692.2001.00494.x.CrossRefPubMed

24.

Wong V, Guzman Rojas R, Shek KL, et al. Laparoscopic sacrocolpopexy: how low does the mesh go? Ultrasound Obstet Gynecol. 2017;49:404–8. https://doi.org/10.1002/uog.15882.CrossRefPubMed

25.

Svabík K, Martan A, Masata J, et al. Ultrasound appearances after mesh implantation—evidence of mesh contraction or folding? Int Urogynecol J. 2011;22:529–33. https://doi.org/10.1007/s00192-010-1308-9.CrossRefPubMed

26.

Dindo D, Demartines N, Clavien P-A. Classification of surgical complications. Ann Surg. 2004;240:205–13. https://doi.org/10.1097/01.sla.0000133083.54934.ae.CrossRefPubMedPubMedCentral

27.

Turner L, Lavelle E, Lowder JL, Shepherd JP. The impact of obesity on intraoperative complications and prolapse recurrence after minimally invasive sacrocolpopexy. Female Pelvic Med Reconstr Surg. 2016;22:317–23. https://doi.org/10.1097/SPV.0000000000000278.CrossRefPubMed

28.

Thubert T, Naveau A, Letohic A, et al. Outcomes and feasibility of laparoscopic sacrocolpopexy among obese versus non-obese women. Int J Gynecol Obstet. 2013;120:49–52. https://doi.org/10.1016/j.ijgo.2012.07.020.CrossRef

29.

Mahoney C, Scott G, Dwyer L, et al. Laparoscopic sacrocolpopexy posthysterectomy: intraoperative feasibility and safety in obese women compared with women of normal weight. Int Urogynecol J. 2019. https://doi.org/10.1007/s00192-019-03888-y.

Title: Obesity and its long-term impact on sacrocolpopexy key outcomes (OBELISK)
Authors: Martin Smazinka
Vladimir Kalis
Martin Havir
Linda Havelkova
Khaled M. Ismail
Zdenek Rusavy
Publication date: 01-08-2020
Publisher: Springer International Publishing
Keywords: Obesity
Obesity
Sacrocolpopexy
Overweight
Published in: International Urogynecology Journal / Issue 8/2020
Print ISSN: 0937-3462
Electronic ISSN: 1433-3023
DOI: https://doi.org/10.1007/s00192-019-04076-8

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Obesity and its long-term impact on sacrocolpopexy key outcomes (OBELISK)

Abstract

Introduction and hypothesis

Methods

Results

Conclusions

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Introduction and hypothesis

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 8/2020

MR scan evaluation of pelvic organ prolapse mesh complications and agreement with intra-operative findings

LeFort partial colpocleisis: tips and technique

Response to letter to the editor

Current trends in urogynecological surgeries in Poland

Effect of investigative laparoscopy on bladder pain syndrome: a prospective cohort trial

Understanding bladder pain syndrome/interstitial cystitis